• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA 加工基因可鉴定 RNA 剪接,并进一步对低级别神经胶质瘤进行分层。

RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.

机构信息

Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.

Chinese Glioma Genome Atlas, Beijing, China.

出版信息

JCI Insight. 2019 Aug 13;5(17):130591. doi: 10.1172/jci.insight.130591.

DOI:10.1172/jci.insight.130591
PMID:31408440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6777941/
Abstract

BACKGROUND

Aberrant expression of RNA processing genes may drive the alterative RNA profile in lower-grade gliomas (LGGs). Thus, we aimed to further stratify LGGs based on the expression of RNA processing genes.

METHODS

This study included 446 LGGs from The Cancer Genome Atlas (TCGA, training set) and 171 LGGs from the Chinese Glioma Genome Atlas (CGGA, validation set). The least absolute shrinkage and selection operator (LASSO) Cox regression algorithm was conducted to develop a risk-signature. The receiver operating characteristic (ROC) curves and Kaplan-Meier curves were used to study the prognosis value of the risk-signature.

RESULTS

Among the tested 784 RNA processing genes, 276 were significantly correlated with the OS of LGGs. Further LASSO Cox regression identified a 19-gene risk-signature, whose risk score was also an independently prognosis factor (P<0.0001, multiplex Cox regression) in the validation dataset. The signature had better prognostic value than the traditional factors "age", "grade" and "WHO 2016 classification" for 3- and 5-year survival both two datasets (AUCs > 85%). Importantly, the risk-signature could further stratify the survival of LGGs in specific subgroups of WHO 2016 classification. Furthermore, alternative splicing events for genes such as EGFR and FGFR were found to be associated with the risk score. mRNA expression levels for genes, which participated in cell proliferation and other processes, were significantly correlated to the risk score.

CONCLUSIONS

Our results highlight the role of RNA processing genes for further stratifying the survival of patients with LGGs and provide insight into the alternative splicing events underlying this role.

摘要

背景

RNA 处理基因的异常表达可能导致低级别胶质瘤(LGG)中 RNA 谱的改变。因此,我们旨在根据 RNA 处理基因的表达进一步对 LGG 进行分层。

方法

本研究纳入了来自癌症基因组图谱(TCGA,训练集)的 446 例 LGG 和来自中国胶质瘤基因组图谱(CGGA,验证集)的 171 例 LGG。采用最小绝对收缩和选择算子(LASSO)Cox 回归算法构建风险特征。采用接收者操作特征(ROC)曲线和 Kaplan-Meier 曲线研究风险特征的预后价值。

结果

在测试的 784 个 RNA 处理基因中,有 276 个与 LGG 的 OS 显著相关。进一步的 LASSO Cox 回归确定了一个 19 基因风险特征,其风险评分也是验证数据集的独立预后因素(P<0.0001,多因素 Cox 回归)。该特征在两个数据集的 3 年和 5 年生存率方面均具有比传统因素“年龄”、“分级”和“2016 年 WHO 分类”更好的预后价值(AUCs > 85%)。重要的是,该风险特征可进一步分层特定 2016 年 WHO 分类亚组的 LGG 患者的生存情况。此外,发现 EGFR 和 FGFR 等基因的剪接事件与风险评分相关。参与细胞增殖和其他过程的基因的 mRNA 表达水平与风险评分显著相关。

结论

我们的研究结果突出了 RNA 处理基因在进一步分层 LGG 患者生存方面的作用,并深入了解了这一作用背后的剪接事件。

相似文献

1
RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.RNA 加工基因可鉴定 RNA 剪接,并进一步对低级别神经胶质瘤进行分层。
JCI Insight. 2019 Aug 13;5(17):130591. doi: 10.1172/jci.insight.130591.
2
Identification and validation of a 21-mRNA prognostic signature in diffuse lower-grade gliomas.鉴别和验证弥漫性低级别神经胶质瘤中 21 个 mRNA 的预后签名。
J Neurooncol. 2020 Jan;146(1):207-217. doi: 10.1007/s11060-019-03372-z. Epub 2019 Dec 18.
3
A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.由六个免疫基因组成的风险评分特征可预测低级别胶质瘤患者的总生存期。
Comput Math Methods Med. 2022 Feb 11;2022:2558548. doi: 10.1155/2022/2558548. eCollection 2022.
4
Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas.miRNA 特征作为低级别胶质瘤患者新型生物标志物的预后价值。
J Neurooncol. 2018 Mar;137(1):127-137. doi: 10.1007/s11060-017-2704-5. Epub 2017 Dec 4.
5
An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.预测低级别胶质瘤预后的免疫相关标志物。
Front Immunol. 2020 Dec 8;11:603341. doi: 10.3389/fimmu.2020.603341. eCollection 2020.
6
RNA processing genes characterize RNA splicing and further stratify colorectal cancer.RNA 加工基因可表征 RNA 剪接,并进一步对结直肠癌进行分层。
Cell Prolif. 2020 Aug;53(8):e12861. doi: 10.1111/cpr.12861. Epub 2020 Jun 28.
7
Expression and prognostic value of mRNAs in lower grade glioma with MGMT promoter methylated.MGMT 启动子甲基化的低级别胶质瘤中 mRNAs 的表达及其预后价值。
J Clin Neurosci. 2020 May;75:45-51. doi: 10.1016/j.jocn.2020.03.037. Epub 2020 Mar 28.
8
Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.鉴定和验证与低级别胶质瘤相关的能量代谢 lncRNA-mRNA 特征。
Biomed Res Int. 2020 Jul 27;2020:3708231. doi: 10.1155/2020/3708231. eCollection 2020.
9
Cell aging related genes can be used to characterize clinical prognoses and further stratify diffuse gliomas.细胞衰老相关基因可用于临床预后特征分析,并进一步对弥漫性神经胶质瘤进行分层。
Sci Rep. 2021 Sep 30;11(1):19493. doi: 10.1038/s41598-021-98913-w.
10
Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas.DNA甲基化与基因表达的综合分析确定了一个用于预测低级别胶质瘤预后的三基因特征。
Cell Physiol Biochem. 2018;47(1):428-439. doi: 10.1159/000489954. Epub 2018 May 18.

引用本文的文献

1
A Bioinformatics Analysis on the Subtypes of Hepatocellular Carcinoma Related to RNA Processing Genes to Reveal Prognosis and Immune Microenvironment Features.一项关于与RNA加工基因相关的肝细胞癌亚型的生物信息学分析,以揭示预后和免疫微环境特征。
Dig Dis Sci. 2025 Jul 28. doi: 10.1007/s10620-025-09261-y.
2
Expressions of the satellite repeat HSAT5 and transposable elements are implicated in disease progression and survival in glioma.卫星重复序列HSAT5和转座元件的表达与胶质瘤的疾病进展和生存期有关。
Turk J Biol. 2024 Jul 1;48(4):242-256. doi: 10.55730/1300-0152.2700. eCollection 2024.
3
O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N-methyladenosine-dependent manner.O-GlcNAc 修饰的 YTHDF2 通过 N6-甲基腺苷依赖性方式促进 HBV 相关肝细胞癌进展。
Signal Transduct Target Ther. 2023 Feb 10;8(1):63. doi: 10.1038/s41392-023-01316-8.
4
Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011-2017): a multicenter retrospective study from CGGA.中国弥漫性神经胶质瘤不同分子亚型患者的临床管理和生存结局(2011-2017):来自 CGGA 的一项多中心回顾性研究。
Cancer Biol Med. 2022 Nov 1;19(10):1460-76. doi: 10.20892/j.issn.2095-3941.2022.0469.
5
HNRNPU promotes the progression of triple-negative breast cancer via RNA transcription and alternative splicing mechanisms.HNRNPU 通过 RNA 转录和可变剪接机制促进三阴性乳腺癌的进展。
Cell Death Dis. 2022 Nov 8;13(11):940. doi: 10.1038/s41419-022-05376-6.
6
RNA 5-Methylcytosine Regulators Contribute to Metabolism Heterogeneity and Predict Prognosis in Ovarian Cancer.RNA 5-甲基胞嘧啶调节剂促成卵巢癌的代谢异质性并预测其预后。
Front Cell Dev Biol. 2022 Mar 18;10:807786. doi: 10.3389/fcell.2022.807786. eCollection 2022.
7
YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated mA modification to activate NF-κB and promote the malignant progression of glioma.YTHDF2 通过识别 METTL3 介导的 mA 修饰来促进 UBXN1 mRNA 的降解,从而激活 NF-κB 并促进神经胶质瘤的恶性进展。
J Hematol Oncol. 2021 Jul 10;14(1):109. doi: 10.1186/s13045-021-01124-z.
8
Identification of a Prognostic Signature Model with Tumor Microenvironment for predicting Disease-free Survival after Radical Prostatectomy.用于预测根治性前列腺切除术后无病生存期的肿瘤微环境预后特征模型的鉴定。
J Cancer. 2021 Feb 22;12(8):2371-2384. doi: 10.7150/jca.51173. eCollection 2021.
9
The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma.胶质母细胞瘤中治疗抵抗和肿瘤复发的多方面因素。
Cells. 2021 Feb 24;10(3):484. doi: 10.3390/cells10030484.
10
A comprehensive model including preoperative peripheral blood inflammatory markers for prediction of the prognosis of diffuse spinal cord astrocytoma following surgery.一个包含术前外周血炎症标志物的综合模型,用于预测弥漫性脊髓星形细胞瘤手术后的预后。
Eur Spine J. 2021 Oct;30(10):2857-2866. doi: 10.1007/s00586-021-06724-4. Epub 2021 Jan 25.

本文引用的文献

1
Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.系统地描述 1p/19q 非缺失型脑胶质瘤中 1p19q 基因的临床和生物学意义。
Carcinogenesis. 2019 Oct 16;40(10):1229-1239. doi: 10.1093/carcin/bgz102.
2
mA RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas.mA RNA甲基化调节因子促进胶质瘤的恶性进展并具有临床预后影响。
Aging (Albany NY). 2019 Feb 27;11(4):1204-1225. doi: 10.18632/aging.101829.
3
Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor.继发性胶质母细胞瘤的突变特征指导脑肿瘤中针对 MET 的靶向试验。
Cell. 2018 Nov 29;175(6):1665-1678.e18. doi: 10.1016/j.cell.2018.09.038. Epub 2018 Oct 18.
4
A novel analytical model of MGMT methylation pyrosequencing offers improved predictive performance in patients with gliomas.一种新型的 MGMT 甲基化焦磷酸测序分析模型可提高脑胶质瘤患者的预测性能。
Mod Pathol. 2019 Jan;32(1):4-15. doi: 10.1038/s41379-018-0143-2. Epub 2018 Oct 5.
5
cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".cIMPACT-NOW更新3:“弥漫性星形细胞胶质瘤,IDH野生型,具有胶质母细胞瘤分子特征,WHO四级”的推荐诊断标准。
Acta Neuropathol. 2018 Nov;136(5):805-810. doi: 10.1007/s00401-018-1913-0. Epub 2018 Sep 26.
6
Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma.鉴定 IDH 突变型胶质瘤中与预后相关的缺氧相关基因集。
Int J Mol Sci. 2018 Sep 25;19(10):2903. doi: 10.3390/ijms19102903.
7
Long non-coding RNA SNHG12promotes the proliferation and migration of glioma cells by binding to HuR.长链非编码 RNA SNHG12 通过与 HuR 结合促进神经胶质瘤细胞的增殖和迁移。
Int J Oncol. 2018 Sep;53(3):1374-1384. doi: 10.3892/ijo.2018.4478. Epub 2018 Jul 11.
8
Transcriptome-Wide Analysis Reveals the Landscape of Aberrant Alternative Splicing Events in Liver Cancer.转录组全分析揭示肝癌中异常可变剪接事件的全景
Hepatology. 2019 Jan;69(1):359-375. doi: 10.1002/hep.30158. Epub 2018 Dec 18.
9
IDH mutation status is associated with distinct vascular gene expression signatures in lower-grade gliomas.异柠檬酸脱氢酶(IDH)突变状态与低级别胶质瘤中独特的血管基因表达特征相关。
Neuro Oncol. 2018 Oct 9;20(11):1505-1516. doi: 10.1093/neuonc/noy088.
10
Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.新型改良的 IDH 突变型星形细胞瘤分级系统。
Acta Neuropathol. 2018 Jul;136(1):153-166. doi: 10.1007/s00401-018-1849-4. Epub 2018 Apr 23.